Beck Enemark, M., Monrad, I., Madsen, C., Lystlund Lauridsen, K., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S. J., d'Amore, F. & Ludvigsen, M. (2021). PD-1 Expression in Pre-Treatment Follicular Lymphoma Predicts the Risk of Subsequent High-Grade Transformation. OncoTargets and Therapy, 14, 481-489. https://doi.org/10.2147/OTT.S289337

Vajavaara, H., Ekeblad, F., Holte, H., Jorgensen, J., Leivonen, S.-K., Berglund, M., Kamper, P., Moller, H. J., D'Amore, F., Molin, D., Enblad, G., Ludvigsen, M., Glimelius, I. & Leppa, S. (2021). Prognostic impact of soluble CD163 in patients with diffuse large Bcell lymphoma. Haematologica, 106(9), 2502-2506. https://doi.org/10.3324/haematol.2020.278182

Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Stender, M. T., Thorlacius-Ussing, O. & Honoré, B. (2021). Proteomic Characterization of Colorectal Cancer Tissue from Patients Identifies Novel Putative Protein Biomarkers. Current issues in molecular biology, 43(2), 1043-1056. https://doi.org/10.3390/cimb43020074

Holst, J. M., Enemark, M. B., Pedersen, M. B., Lauridsen, K. L., Hybel, T. E., Clausen, M. R., Frederiksen, H., Møller, M. B., Nørgaard, P., Plesner, T. L., Hamilton-Dutoit, S. J., D’amore, F., Honoré, B. & Ludvigsen, M. (2021). Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia. Cancers, 13(21), Article 5526. https://doi.org/10.3390/cancers13215526

Vajavaara, H., Mortensen, J. B., Leivonen, S.-K., Hansen, I. M., Ludvigsen, M., Holte, H., Jørgensen, J., Bjerre, M., d'Amore, F. & Leppä, S. (2021). Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma. Cancers, 13(3), Article 398. https://doi.org/10.3390/cancers13030398

Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021). Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies. European Journal of Haematology, 107(1), 81-91. https://doi.org/10.1111/ejh.13621

Kim, S. J., Lim, J. Q., Laurensia, Y., Cho, J., Yoon, S. E., Lee, J. Y., Ryu, K. J., Ko, Y. H., Koh, Y., Cho, D., Lim, S. T., Beck Enemark, M., D'amore, F., Bjerre, M., Ong, C. K. & Kim, W. S. (2020). Avelumab for the treatment of relapsed or refractory extranodal NK/T-cell lymphoma: an open-label phase 2 study. Blood, 136(24), 2754-2763. https://doi.org/10.1182/blood.2020007247

Vonasek, J., Edslev, P. W., d'Amore, F. & Hasle, H. (2020). Brentuximab vedotin monotherapy is an effective treatment in a frail pediatric patient with Down syndrome and classical Hodgkin lymphoma. Pediatric Blood & Cancer, 67(2), Article e28082. https://doi.org/10.1002/pbc.28082

Soerensen, J. F., Aggerholm, A., Kerndrup, G. B., Hansen, M. C., Ewald, I. K. L., Bill, M., Ebbesen, L. H., Rosenberg, C. A., Hokland, P., Ludvigsen, M. & Stidsholt Roug, A. (2020). Clonal hematopoiesis predicts development of therapy-related myeloid neoplasms post-autologous stem cell transplantation. Blood Advances, 4(5), 885-892. https://doi.org/10.1182/bloodadvances.2019001157

Monrad, I., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020). Glycolytic biomarkers predict transformation in patients with follicular lymphoma. PLOS ONE, 15(5), Article e0233449. https://doi.org/10.1371/journal.pone.0233449

Holst, J. M., Ludvigsen, M., Hamilton-Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B., Steiniche, T., Rabinovich, G. A., d'Amore, F. & Pedersen, M. B. (2020). High intratumoural galectin-1 expression predicts adverse outcome in ALK- ALCL and CD30+ PTCL-NOS. Hematological Oncology, 38(1), 59-66. https://doi.org/10.1002/hon.2702

Vähämurto, P., Pollari, M., Clausen, M. R., D’amore, F., Leppä, S. & Mannisto, S. (2020). Low absolute lymphocyte counts in the peripheral blood predict inferior survival and improve the international prognostic index in testicular diffuse large b-cell lymphoma. Cancers, 12(7), Article 1967. https://doi.org/10.3390/cancers12071967

Holst, J. M., Plesner, T. L., Pedersen, M. B., Frederiksen, H., Møller, M. B., Clausen, M. R., Hansen, M. C., Hamilton-Dutoit, S. J., Nørgaard, P., Johansen, P., Eberlein, T. R., Mortensen, B. K., Mathiasen, G., Øvlisen, A., Wang, R., Wang, C., Zhang, W., Ommen, H. B., Stentoft, J. ... d'Amore, F. (2020). Myeloproliferative and lymphoproliferative malignancies occurring in the same patient: a nationwide discovery cohort. Haematologica, 105(10), 2432-2439. https://doi.org/10.3324/haematol.2019.225839

Clausen, M. R., Ulrichsen, S. P., Juul, M. B., Poulsen, C. B., Iversen, B., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M. & d'Amore, F. (2020). Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study. Hematological Oncology, 38(3), 318-325. https://doi.org/10.1002/hon.2734

Ludvigsen, M., Thorlacius-Ussing, L., Vorum, H., Moyer, M. P., Stender, M. T., Thorlacius-Ussing, O. & Honoré, B. (2020). Proteomic Characterization of Colorectal Cancer Cells versus Normal-Derived Colon Mucosa Cells: Approaching Identification of Novel Diagnostic Protein Biomarkers in Colorectal Cancer. International Journal of Molecular Sciences , 21(10), Article 3466. https://doi.org/10.3390/ijms21103466

Madsen, C., Plesner, T. L., Bentzen, H. H. N., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L., Ludvigsen, M. & d'Amore, F. A. (2020). Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leukemia & Lymphoma, 61(11), 2584-2594 . https://doi.org/10.1080/10428194.2020.1779254

Lugtenburg, P. J., De Nully Brown, P., Van der Holt, B., D'Amore, F. A., Koene, H. R., De Jongh, E., Fijnheer, R., Van Esser, J. W., Bohmer, L. H., Pruijt, J. F., Verhoef, G. E., Hoogendoorn, M., Bilgin, M. Y., Nijland, M., Van der Burg-De Graauw, N. C., Oosterveld, M., Jie, K. S. G., Larsen, T. S., Van der Poel, M. W. ... Zijlstra-Baalbergen, J. M. (2020). Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84). Journal of Clinical Oncology, 38(29), 3377-3387. https://doi.org/10.1200/JCO.19.03418

Snipsøyr, M. G., Wiggers, H., Ludvigsen, M., Stensballe, A., Vorum, H., Poulsen, S. H., Rasmussen, L. M., Petersen, E. & Honoré, B. (2020). Towards identification of novel putative biomarkers for infective endocarditis by serum proteomic analysis. International Journal of Infectious Diseases, 96, 73-81. https://doi.org/10.1016/j.ijid.2020.02.026

Simonsen, A. T., Bill, M., Rosenberg, C. A., Hansen, M. H., Møller, P. L., Kjeldsen, E., Johansen, K. D., Ommen, H. B., Nederby, L., Aggerholm, A., Hokland, P. & Ludvigsen, M. (2020). Unraveling clonal heterogeneity at the stem cell level in myelodysplastic syndrome: In pursuit of cell subsets driving disease progression. Leukemia Research, 92, Article 106350. https://doi.org/10.1016/j.leukres.2020.106350

Clausen, M. R., Ulrichsen, S. P., Larsen, T. S., Poulsen, C. B., Tojaga, S., Pedersen, P. T., Madsen, J., Pedersen, R. S., Josefsson, P. L., Gørløv, J. S., Nørgaard, M. & d'Amore, F. (2019). Depth of neutrophil nadir after first cycle of R-CHOP predicts outcome in diffuse large B-cell lymphoma - a nationwide population-based cohort study. Leukemia & Lymphoma, 60(8), 1950-1957. https://doi.org/10.1080/10428194.2018.1554863

Bro, M. L., Johansen, C., Vuust, P., Enggaard, L., Himmelstrup, B., Mourits-Andersen, T., Brown, P., d'Amore, F., Andersen, E. A. W., Abildgaard, N. & Gram, J. (2019). Effects of live music during chemotherapy in lymphoma patients: a randomized, controlled, multi-center trial. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 27(10), 3887-3896. https://doi.org/10.1007/s00520-019-04666-8

Pedersen, M. A., Gormsen, L. C., Kamper, P., Wassberg, C., Andersen, M. D., d'Amore, A. L., Barrington, S. F., Johnson, P., Hamilton-Dutoit, S., Amini, R. M., Enblad, G., Molin, D. & d'Amore, F. (2019). Focal skeletal FDG uptake indicates poor prognosis in cHL regardless of extent and first-line chemotherapy. British Journal of Haematology, 186(3), 431-439. https://doi.org/10.1111/bjh.15933

Heavican, T. B., Bouska, A., Yu, J., Lone, W. G., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., Greiner, T. C., Vose, J., Weisenburger, D. D., Lachel, C., Wang, C., Fu, K., Stevens, J., Lim, S. T., Ong, C. K. ... Iqbal, J. (2019). Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma. Blood, 133(15), 1664-1676. https://doi.org/10.1182/blood-2018-09-872549

Madsen, C., Lauridsen, K. L., Plesner, T. L., Monrad, I., Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019). High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma. Blood Cancer Journal, 9(4), Article 35. https://doi.org/10.1038/s41408-019-0197-5

Calabretta, E., D’amore, F. & Carlo-Stella, C. (2019). Immune and inflammatory cells of the tumor microenvironment represent novel therapeutic targets in classical hodgkin lymphoma. International Journal of Molecular Sciences , 20(21), Article 5503. https://doi.org/10.3390/ijms20215503

Mannisto, S., Vähämurto, P., Pollari, M., Clausen, M. R., Jyrkkiö, S., Kellokumpu-Lehtinen, P. L., Kovanen, P., Karjalainen-Lindsberg, M. L., d'Amore, F. & Leppä, S. (2019). Intravenous but not intrathecal central nervous system–directed chemotherapy improves survival in patients with testicular diffuse large B-cell lymphoma. European Journal of Cancer, 115, 27-36. https://doi.org/10.1016/j.ejca.2019.04.004

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Lykke Eriksen, P., Pedersen, A. K. N., Honoré, B. & Mortensen, F. V. (2019). Perturbations of urea cycle enzymes during post-hepatectomy rat liver failure. American Journal of Physiology: Gastrointestinal and Liver Physiology, 317(4), G429-G440. https://doi.org/10.1152/ajpgi.00293.2018

Barrenetxea Lekue, C., Grasso Cicala, S., Leppä, S., Stauffer Larsen, T., Herráez Rodríguez, S., Alonso Caballero, C., Jørgensen, J. M., Toldbod, H., Leal Martínez, I. & D’Amore, F. (2019). Pixantrone beyond monotherapy: a review. Annals of Hematology, 98(9), 2025-2033. https://doi.org/10.1007/s00277-019-03749-0

Clausen, M. R., Maurer, M. J., Ulrichsen, S. P., Larsen, T. S., Himmelstrup, B., Rønnov-Jessen, D., Link, B. K., Feldman, A. L., Slager, S. L., Nowakowski, G. S., Thompson, C. A., Pedersen, P. T., Madsen, J., Pedersen, R. S., Gørløv, J. S., Cerhan, J. R., Nørgaard, M. & D’amore, F. (2019). Pretreatment hemoglobin adds prognostic information to the nccn-ipi in patients with diffuse large b-cell lymphoma treated with anthracycline-containing chemotherapy. Clinical epidemiology, 11, 987-996. https://doi.org/10.2147/CLEP.S219595

O'Connor, O. A., Özcan, M., Jacobsen, E. D., Roncero, J. M., Trotman, J., Demeter, J., Masszi, T., Pereira, J., Ramchandren, R., Beaven, A., Caballero, D., Horwitz, S. M., Lennard, A., Turgut, M., Hamerschlak, N., d'Amore, F. A., Foss, F., Kim, W.-S., Leonard, J. P. ... Lumiere Study Investigators (2019). Randomized ohase III study of alisertib or investigator's choice (selected single agent) in patients with relapsed or refractory peripheral T-Cell lymphoma. Journal of Clinical Oncology, 37(8), 613-623. https://doi.org/10.1200/JCO.18.00899

Amador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W. G., Bouska, A., D'amore, F., Bjerregård Pedersen, M., Pileri, S. A., Agostinelli, C., Feldman, A. L., Rosenwald, A., Ott, G., Mottok, A., Savage, K. J., de Leval, L., Gaulard, P., Lim, S. T. ... Lymphoma/Leukemia Molecular Profiling Project (2019). Reproducing the Molecular Subclassification of Peripheral T-cell Lymphoma-NOS by Immunohistochemistry. Blood, 134(24), 2159-2170. https://doi.org/10.1182/blood.2019000779

Andersen, M. D., Kamper, P., d’Amore, A., Clausen, M., Bentzen, H. & d'Amore, F. (2019). The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor^†. Leukemia & Lymphoma, 60(4), 927-933. https://doi.org/10.1080/10428194.2018.1515939

Hansen, J. J., Beier Ommen, H., Gormsen, L. C., d'Amore, F. A. & Hjørnet Kamper, P. M. (2018). Classical Hodgkin Lymphoma Presenting with Severe, Recurrent Hypothermic Episodes. Case Reports in Hematology, 2018, Article 3726593. https://doi.org/10.1155/2018/3726593

Luchtel, R. A., Dasari, S., Oishi, N., Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J., Wang, X., Katoh, R., Dogan, A., Kip, N. S., Cunningham, J. M., Sun, Z., Baheti, S., Porcher, J. C., Said, J. W., Jiang, L., Hamilton-Dutoit, S. J. ... Feldman, A. L. (2018). Molecular profiling reveals immunogenic cues in anaplastic large cell lymphomas with DUSP22 rearrangements. Blood, 132(13), 1386-1398. https://doi.org/10.1182/blood-2018-03-838524

Ludvigsen, M., Bjerregård Pedersen, M., Lystlund Lauridsen, K., Svenstrup Poulsen, T., Hamilton-Dutoit, S. J., Besenbacher, S., Bendix, K., Møller, M. B., Nørgaard, P., d'Amore, F. & Honoré, B. (2018). Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified. Blood Advances, 2(19), 2533-2542. https://doi.org/10.1182/bloodadvances.2018019893

Kwong, YL., Kim, SJ., Tse, E., Oh, SJ., Kwak, JY., Eom, HS., Do, YR., Mun, YC., Lee, SR., Shin, HJ., Suh, C., Chuang, SS., Tan, D., Lim, ST., Izutsu, K., Suzuki, R., Relander, T., d'Amore, F. A., Schmitz, N. ... Kim, WS. (2018). Sequential chemotherapy/radiotherapy was comparable with concurrent chemoradiotherapy for stage I/II NK/T-cell lymphoma. Annals of Oncology, 29(1), 256–263. https://doi.org/10.1093/annonc/mdx684

Christensen, M. S., Vestergaard, J. M., d'Amore, F., Gørløv, J. S., Toft, G., Ramlau-Hansen, C. H., Stokholm, Z. A., Iversen, I. B., Nissen, M. S. & Kolstad, H. A. (2018). Styrene Exposure and Risk of Lymphohematopoietic Malignancies in 73,036 Reinforced Plastics Workers. Epidemiology, 29(3), 342-351. https://doi.org/10.1097/EDE.0000000000000819

Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T., Bentzen, H. H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D., Jensen, K. R., Pettinger, A. M., Ludvigsen, M., Leppä, S. & d'Amore, F. A. (2018). Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study. Blood Advances, 2(13), 1562-1571. https://doi.org/10.1182/bloodadvances.2018017673

Modvig, L., Vase, M. & d'Amore, F. (2017). Clinical and treatment-related features determining the risk of late relapse in patients with diffuse large B-cell lymphoma. British Journal of Haematology, 179(1), 75-82. https://doi.org/10.1111/bjh.14822

Kharfan-Dabaja, M. A., Kumar, A., Ayala, E., Hamadani, M., Reimer, P., Gisselbrecht, C., d'Amore, F., Jantunen, E., Ishida, T., Bazarbachi, A., Foss, F., Advani, R., Fenske, T. S., Lazarus, H. M., Friedberg, J. W., Aljurf, M., Sokol, L., Tobinai, K., Tse, E. ... Savani, B. N. (2017). Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T-Cell and NK/T-Cell Lymphomas: an International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 23(11), 1826-1838. https://doi.org/10.1016/j.bbmt.2017.07.027

Bouska, A., Zhang, W., Gong, Q., Iqbal, J., Scuto, A., Vose, J., Ludvigsen, M., Fu, K., Weisenburger, D. D., Greiner, T. C., Gascoyne, R. D., Rosenwald, A., Ott, G., Campo, E., Rimsza, L. M., Delabie, J., Jaffe, E. S., Braziel, R. M., Connors, J. M. ... Chan, W. C. (2017). Combined copy number and mutation analysis identifies oncogenic pathways associated with transformation of follicular lymphoma. Leukemia, 31(1), 83-91. https://doi.org/10.1038/leu.2016.175

Møller, M., Rath, M. F., Ludvigsen, M., Honoré, B. & Vorum, H. (2017). Diurnal expression of proteins in the retina of the blind cone-rod homeobox (Crx(-/-) ) mouse and the 129/Sv mouse: a proteomic study. Acta Ophthalmologica, 7(95), 717-726. https://doi.org/10.1111/aos.13429

Pedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P., Møller, M. B., Steiniche, T., d'Amore, F. & Feldman, A. L. (2017). DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood, 130(4), 554-557. https://doi.org/10.1182/blood-2016-12-755496

Pedersen, M. B., Hamilton Dutoit, S. J., Bendix, K., Ketterling, RP., Bedroske, PP., Luoma, IM., CA, S., Bennani-Baiti, N., Nørgaard, P., Møller, MB., Steiniche, T. & d'Amore, F. A. (2017). First independent validation fo DUSP22 and TP63 rearrangements as outcome predictors in ALK-negative anaplastic large cell lymphoma: a Danish cohort study. Blood.

Holst, J. M., Ludvigsen, M., Hamilton Dutoit, S. J., Bendix, K., Plesner, T. L., Nørgaard, P., Møller, M. B., Steiniche, T., Rabinovich, G. A., d'Amore, F. A. & Pedersen, M. B. (2017). High Intratumoral Galectin-1 Is Associated with Adverse Outcome in ALK-Negative, CD30-Positive Peripheral T-Cell Lymphomas. Blood, 130(Suppl 1), 4079-4079.

Hollander, P., Kamper, P., Smedby, K., Enblad, G., Ludvigsen, M., Mortensen, J., Amini, RM., Hamilton Dutoit, S. J., d'Amore, F. A., Molin, D. & Glimelius, I. (2017). High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome. Blood Advances, 1(18), 1427-1439. https://doi.org/10.1182/bloodadvances.2017006346

Jensen, A., Stausbøl-Grøn, B., Riber-Hansen, R. & d'Amore, F. (2017). Ibrutinib-Associated Skin Toxicity: A Case of Maculopapular Rash in a 79-Year Old Caucasian Male Patient with Relapsed Waldenstrom's Macroglobulinemia and Review of the Literature. Dermatology Reports, 9(1), 6976. https://doi.org/10.4081/dr.2017.6976